By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epitomics, Inc. 

863 Mitten Road
Suite 103
Burlingame  California  94010-1303  U.S.A.
Phone: 650-583-6688 Fax: 650-583-6680



Company News
Abcam plc (ABC.L) Buys Epitomics, Inc. for $170 Million 3/7/2012 7:47:35 AM
Leica Microsystems and Epitomics, Inc. Enter Agreement for Supply of Proprietary Rabbit Monoclonal Antibodies 2/29/2012 10:45:12 AM
Epitomics, Inc. and University of California, Davis (UCD), Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions 12/22/2011 9:37:02 AM
Epitomics, Inc. Receives Notice of Allowance from the United States Patent and Trademark Office for a Novel Method for Identifying Differentially Expressed Proteins 11/1/2011 6:24:21 AM
Epitomics, Inc. Plans Taiwan IPO Later in 2011 8/19/2011 9:22:26 AM
Epitomics, Inc. Releases New Antibodies Developed With the National Cancer Institute's Center for Cancer Research 7/27/2011 5:49:41 AM
Epitomics, Inc. Signs Agreement With Bayer HealthCare AG (BAY) for Antibody Technology 5/26/2011 7:53:50 AM
Dako A/S and Epitomics, Inc. Enter into Strategic Alliance on Developing and Launching State-Of-The-Art IHC Diagnostic Monoclonal Antibodies 3/21/2011 8:26:57 AM
Epitomics, Inc. Signs Antibody Development Agreement With the National Cancer Institute 12/16/2010 6:27:19 AM
Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation 9/20/2010 9:19:37 AM